These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7029272)

  • 1. Detection of mammalian cell mutagens in urine from carcinogen-dosed mice.
    Amacher DE; Turner GN; Ellis JH
    Mutat Res; 1981 Sep; 90(1):79-90. PubMed ID: 7029272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of liver postmitochondrial fraction concentration from Aroclor 1254-treated rats on promutagen activation in L5178Y cells.
    Amacher DE; Turner GN
    Mutat Res; 1982 Apr; 97(2):131-7. PubMed ID: 7078576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of trifluorothymidine-resistant mutants by metal ions in L5178Y/TK+/- cells.
    Amacher DE; Paillet SC
    Mutat Res; 1980 Jul; 78(3):279-88. PubMed ID: 7432364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine bladder urothelial cell activation of carcinogens to metabolites mutagenic to Chinese hamster V79 cells and Salmonella typhimurium.
    Oglesby LA; Hix C; Snow L; MacNair P; Seig M; Langenbach R
    Cancer Res; 1983 Nov; 43(11):5194-9. PubMed ID: 6352016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activation of procarcinogens to mutagens by cultured rat hepatocytes in the L5178Y/TK mutation assay.
    Amacher DE; Paillet SC
    Mutat Res; 1983 Feb; 113(1):77-88. PubMed ID: 6828044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay to coded chemicals. I: Results for nine compounds.
    McGregor DB; Martin R; Cattanach P; Edwards I; McBride D; Caspary WJ
    Environ Mutagen; 1987; 9(2):143-60. PubMed ID: 3102223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hamster hepatocyte-mediated activation of procarcinogens to mutagens in the L5178Y/TK mutation assay.
    Amacher DE; Paillet SC
    Mutat Res; 1982 Dec; 106(2):305-16. PubMed ID: 7155171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome analysis of small and large L5178Y mouse lymphoma cell colonies: comparison of trifluorothymidine-resistant and unselected cell colonies from mutagen-treated and control cultures.
    Blazak WF; Los FJ; Rudd CJ; Caspary WJ
    Mutat Res; 1989 Oct; 224(2):197-208. PubMed ID: 2507912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of N-acetyl-2-aminofluorene to a mutagen in L5178Y/TK+/-mouse lymphoma cells.
    Amacher DE; Paillet SC; Elliott JA
    Mutat Res; 1981 Aug; 89(4):311-20. PubMed ID: 7290097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The L5178Y/TK gene mutation assay for the detection of chemical mutagens.
    Amacher DE; Turner GN
    Ann N Y Acad Sci; 1983; 407():239-52. PubMed ID: 6410961
    [No Abstract]   [Full Text] [Related]  

  • 11. Promutagen activation by rodent-liver postmitochondrial fractions in the L5178Y/TK cell mutation assay.
    Amacher DE; Turner GN
    Mutat Res; 1980 Dec; 74(6):485-501. PubMed ID: 7464853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of urine and faeces after treatment of rats with known genotoxins.
    Willems MI; de Raat WK
    Carcinogenesis; 1985 Jul; 6(7):967-76. PubMed ID: 3893784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of microsomal enzyme inducers on the urinary excretion pattern of mutagenic metabolites of the carcinogen 2,4-toluenediamine.
    Reddy TV; Ramanathan R; Benjamin T; Grantham PH; Weisburger EK
    J Natl Cancer Inst; 1986 Feb; 76(2):291-7. PubMed ID: 3456067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. II. Test validation and interpretation.
    Amacher DE; Paillet SC; Turner GN; Ray VA; Salsburg DS
    Mutat Res; 1980 Aug; 72(3):447-74. PubMed ID: 7453708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/- mouse lymphoma cells.
    Moore MM; Clive D; Hozier JC; Howard BE; Batson AG; Turner NT; Sawyer J
    Mutat Res; 1985 Aug; 151(1):161-74. PubMed ID: 3927157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial mutagenicity testing of urine from rats dosed with 2-ethylhexanol derived plasticizers.
    DiVincenzo GD; Hamilton ML; Mueller KR; Donish WH; Barber ED
    Toxicology; 1985 Mar; 34(3):247-59. PubMed ID: 3883574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the activities of benzo[a]pyrene, benzidine and ethyl methanesulphonate in the L5178Y TK +/- mouse lymphoma mutagenicity assay using standardized and non-standardized protocols.
    Riach CG; Cattanach PJ; Howgate S; Shepherd W; McBride D; Edwards IW; McGregor DB; Combes RD
    Mutagenesis; 1990; 5 Suppl():35-44. PubMed ID: 2184319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of metabolic activation for four mutagens in a bacterial, fungal and two mammalian cell mutagenesis assays.
    Rees RW; Brice AJ; Carlton JB; Gilbert PJ; Mitchell ID
    Mutagenesis; 1989 Sep; 4(5):335-42. PubMed ID: 2687626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial urinary assay in monitoring exposure to mutagens and carcinogens.
    Vainio H; Sorsa M; Falck K
    IARC Sci Publ; 1984; (59):247-58. PubMed ID: 6400094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. I. Application to genetic toxicological testing.
    Amacher DE; Paillet S; Ray VA
    Mutat Res; 1979 Dec; 64(6):391-406. PubMed ID: 392313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.